Correlation Between AgeX Therapeutics and Lineage Cell
Can any of the company-specific risk be diversified away by investing in both AgeX Therapeutics and Lineage Cell at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AgeX Therapeutics and Lineage Cell into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AgeX Therapeutics and Lineage Cell Therapeutics, you can compare the effects of market volatilities on AgeX Therapeutics and Lineage Cell and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AgeX Therapeutics with a short position of Lineage Cell. Check out your portfolio center. Please also check ongoing floating volatility patterns of AgeX Therapeutics and Lineage Cell.
Diversification Opportunities for AgeX Therapeutics and Lineage Cell
-0.25 | Correlation Coefficient |
Very good diversification
The 3 months correlation between AgeX and Lineage is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding AgeX Therapeutics and Lineage Cell Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lineage Cell Therapeutics and AgeX Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AgeX Therapeutics are associated (or correlated) with Lineage Cell. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lineage Cell Therapeutics has no effect on the direction of AgeX Therapeutics i.e., AgeX Therapeutics and Lineage Cell go up and down completely randomly.
Pair Corralation between AgeX Therapeutics and Lineage Cell
If you would invest 74.00 in AgeX Therapeutics on September 2, 2024 and sell it today you would earn a total of 0.00 from holding AgeX Therapeutics or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 1.56% |
Values | Daily Returns |
AgeX Therapeutics vs. Lineage Cell Therapeutics
Performance |
Timeline |
AgeX Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Lineage Cell Therapeutics |
AgeX Therapeutics and Lineage Cell Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with AgeX Therapeutics and Lineage Cell
The main advantage of trading using opposite AgeX Therapeutics and Lineage Cell positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AgeX Therapeutics position performs unexpectedly, Lineage Cell can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lineage Cell will offset losses from the drop in Lineage Cell's long position.AgeX Therapeutics vs. MAIA Biotechnology | AgeX Therapeutics vs. Larimar Therapeutics | AgeX Therapeutics vs. Lyra Therapeutics | AgeX Therapeutics vs. Lineage Cell Therapeutics |
Lineage Cell vs. MAIA Biotechnology | Lineage Cell vs. Armata Pharmaceuticals | Lineage Cell vs. Portage Biotech | Lineage Cell vs. Cadrenal Therapeutics, Common |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Stocks Directory Find actively traded stocks across global markets | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |